Navigation Links
Ontario Supports OHIP’s Rejection of Claim by North York Ma

An advocate called for an immediate review of the standards and guidelines OHIP uses to decide who gets reimbursed for out-of-country treatments// .

Ontario Divisional Court supported OHIP's rejection of the claim of a North York man who hoped to recover the $450,000 cost of his life-saving liver transplant in England. The retired high-school teacher will not be able to recoup any of his health-care costs, the Ontario Divisional Court has ruled.

This week's 33-page decision is a letdown for the North York man, Adolfo Flora, 57, who was told by specialists at Toronto General Hospital, at the time of his diagnosis of advanced liver cancer in November 1999, that he would be lucky to live another eight months.

He was also told that he was not a suitable candidate to receive a deceased donor's liver because the advanced stage of his cancer made his chances of survival slim.

But while exploring other options, a team at Cromwell Hospital in London, England, did a partial transplant from a living donor – his brother, a physician. Flora was given a better than 50% chance of survival.

On Feb. 22, 2000, Flora's physician completed a form seeking OHIP reimbursement for the treatment in England - It was denied because of chemoembolization, one of the procedures performed, which was considered experimental and not part of the insured services.

"I'm disappointed in the outcome," says his lawyer, Mark Freiman, in a telephonic interview yesterday. "It has a very far-ranging impact in terms of defining the obligations of government and the lack of obligations of government in the areas of health care."

The case demonstrates very clearly some of the flaws in the public health system when it comes to covering the cost of medical treatment outside Canada, said George Marcello, the 51-year-old head of Step by Step, an organ transplant advocacy group, who has had two liver transplants himself.

"Let's review the whole standard of who should be able to be medically covered in situations like that," he said.
SRI
'"/>




Related medicine news :

1. Nurses In Ontario demands Safe Disposable Needles
2. Ontario Institute for Cancer Research is funded $142 million
3. Students wants to extent Tution waiver in Ontario
4. Patients In Ontario Wait Longer For Treatment
5. Ontario Unprepared To Deal With Flu Pandemic
6. Ontario’s Entire Drug System Undergoes a Revam
7. Chemotherapy Queues in Ontario Stay Steady
8. Ontario Ranks Highest in Free Bird Flu Vaccination Rates
9. Ontario minister seconds patient-pay plan for expensive cancer drugs
10. Ontario Medical Association Planning To Lure Back Expat Doctors
11. Ontario Addresses Shortage of Transplant Organs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one ... an innovative new design of the shoulder pad. The shoulder pad provides optimal ... controlling your pain while using cold therapy. By utilizing ice and water that is ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... ... 12, 2017 , ... Women-owned and Grand Rapids-based workplace wellness ... in Wellness® by Best and Brightest. OnSite Wellness will be honored at the ... 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located at ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... at the University of California Berkeley, and other leading institutions in announcing the ... power of institutions to change the way animals are raised for food. , ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... HORSHAM, Pa. , Sept. 22, 2017 ... received a complete response letter from the U.S. Food ... (BLA) seeking approval of sirukumab for the treatment of ... response letter indicates additional clinical data are needed to ... of moderately to severely active RA. ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
Breaking Medicine Technology: